Rhelion Life Sciences Corp. (TRUFF)
OTC
Closed
Oct 7, 2026
Day's Range
0.021052 wk Range
0.00500Overview - TRUFF - Rhelion Life Sciences Corp.
Key Statistics
Valuation
Enterprise Value
5.50M
P/E (Trailing)
‪-1.44‬
Price / Sales (TTM)
‪3.36‬
Price / Book
‪0.84‬
EV / EBITDA
‪-1.79‬
Profitability
Gross Margin
‪91.22%‬
Profit Margin
‪-181.28%‬
Operating Margin
‪-774.50%‬
Return on Assets
‪-13.71%‬
Return on Equity
‪-41.31%‬
Ownership
Shares Outstanding
614.12M
Float
575.17M
Held by Insiders
‪5.90%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.96‬
50-Day Avg
‪0.0227‬
200-Day Avg
‪0.0208‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - TRUFF - Rhelion Life Sciences Corp.
Peers - TRUFF - Rhelion Life Sciences Corp.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
- TRUFFOTCRhelion Life Sciences Corp.12.95MMarket Cap-23.22%52-week change-1.44P/E (Trailing)‪-181.28%‬Profit Margin
- MKGAFOTCMerck KGaA67.92BMarket Cap+9.27%52-week change25.32P/E (Trailing)‪11.21%‬Profit Margin
- MKKGYOTCMerck KGaA Sponsored ADR67.10BMarket Cap+8.97%52-week change24.90P/E (Trailing)‪11.21%‬Profit Margin
- GALDYOTCGalderma Group AG Unsponsored ADR45.20BMarket Cap+7.87%52-week change53.10P/E (Trailing)‪14.57%‬Profit Margin
- GDERFOTCGalderma Group AG44.15BMarket Cap+11.81%52-week change51.88P/E (Trailing)‪14.57%‬Profit Margin
- JHPCYOTCJiangsu Hengrui Pharmaceuticals Co. Ltd.43.14BMarket Cap-30.46%52-week change37.14P/E (Trailing)‪86.20%‬Profit Margin
- HLNCFOTCHaleon plc38.69BMarket Cap+1.79%52-week change18.58P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - TRUFF - Rhelion Life Sciences Corp.
About
Rhelion Life Sciences Corp. is a life sciences company focused on the research, development, and commercialization of natural psychedelic medicines and related products. The company operates a pharmaceutical development platform through its subsidiary Filament Health, where it advances naturally derived psilocybin…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
